- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06893432
Cognitive Function and EEG Brain Network Remodeling Among Users of Hearing Aids With ARHL (EEG/ARHL)
Cognitive Function and Electroencephalogram Brain Network Remodeling Among Users of Hearing Aids With Age-Related Hearing Loss
This study intends to retrospectively collect and analyze the case data of patients with age-related hearing loss who were admitted to the Otolaryngology Department of Sun Yat-sen Memorial Hospital from January 2020 to June 2024. Participants were divided into an Aided Group and a Control Group based on whether they had regularly used hearing aids in the past six months.
Audiological, cognitive, emotional, and sleep assessments, as well as resting state electroencephalogram (EEG) features, are supposed to be compared between the two groups.
Study Overview
Status
Intervention / Treatment
Detailed Description
This study intends to retrospectively collect and analyze the case data of patients with age-related hearing loss who were admitted to the Otolaryngology Department of Sun Yat-sen Memorial Hospital from January 2020 to June 2024. Participants were divided into an Aided Group and a Control Group based on whether they had regularly used hearing aids in the past six months.
The audiological assessment comprises pure tone audiometry, speech recognition audiometry, and sound field audiometry. The cognitive assessment includes the Mandarin version of the Montreal Cognitive Assessment (MoCA) and the Mini-Mental State Examination (MMSE). The emotional assessment consists of the 24-item Hamilton Depression Scale (HAMD) and the 15-item Geriatric Depression Scale (GDS). Sleep assessment is conducted using the Pittsburgh Sleep Quality Index (PSQI).
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510000
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosed with ARHL
- Aged between 50 and 90
- Complete measuring data; including pure tone audiometry, speech audiometry, cognitive screening scales and resting-state electroencephalography
- Right-handed
- Regular daily use of hearing aid(s) for six-month period prior to the test date, or no hearing aid experience
Exclusion Criteria:
- Outer/middle ear abnormalities or any other central nervous system disorders
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Aided
Participants who have regularly used hearing aid(s) to improve hearing during the past six-month period.
|
Hearing aids are a common intervention method used to address age-related hearing loss, providing amplified sound to improve hearing clarity and communication abilities for elderly individuals.
|
|
Control
Participants without any experience of using hearing aids.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
better-ear pure-tone averages (BEPTA)
Time Frame: Day1
|
The pure-tone thresholds were tested using a Piano Plus diagnostic audiometer (Inventis, Italy), following the standard Hughson-Westlake method (i.e., up 5 and down 10 dB HL).
Subsequently, the pure tone average (PTA) of air conduction thresholds between 500 and 4000 Hz was calculated ear by ear.
Better-ear PTA of each participant will be collected for further analysis.
|
Day1
|
|
binaural averaged pure-tone averages (BAPTA)
Time Frame: Day1
|
The pure-tone thresholds were tested using a Piano Plus diagnostic audiometer (Inventis, Italy), following the standard Hughson-Westlake method (i.e., up 5 and down 10 dB HL).
Subsequently, the pure tone average (PTA) of air conduction thresholds between 500 and 4000 Hz was calculated ear by ear.
binaural averaged PTA of each participant will be collected for further analysis.
|
Day1
|
|
better-ear speech recognition thresholds (BESRT)
Time Frame: Day1
|
Speech recognition audiometry was tested using a Piano Plus diagnostic audiometer and a Chinese disyllabic version of speech material.
The correct recognition rate at each 10 dB step of test intensity was recorded, covering the full range from 0% to 100% as much as possible.
However, the intensity would cease increasing when it reached the maximum tolerable limit for the participant or the maximum output of the equipment.
Specifically, speech recognition threshold (SRT) was defined as the signal intensity required for the test ear to achieve a 50% correct recognition rate.
Better-ear SRT of each participant will be collected for further analysis.
|
Day1
|
|
binaural averaged speech recognition thresholds (BASRT)
Time Frame: Day1
|
Speech recognition audiometry was tested using a Piano Plus diagnostic audiometer and a Chinese disyllabic version of speech material.
The correct recognition rate at each 10 dB step of test intensity was recorded, covering the full range from 0% to 100% as much as possible.
However, the intensity would cease increasing when it reached the maximum tolerable limit for the participant or the maximum output of the equipment.
Specifically, speech recognition threshold (SRT) was defined as the signal intensity required for the test ear to achieve a 50% correct recognition rate.
binaural averaged SRT of each participant will be collected for further analysis.
|
Day1
|
|
The global and subscores of the Mandarin version of the Montreal Cognitive Assessment (MoCA)
Time Frame: Day1
|
MoCA consists of seven subcomponents, namely visual-spatial function, naming, attention, language, abstraction, delayed recall, and orientation.
It scores based on whether participants answer each item correctly, with a total score of 30.
A higher score indicates better cognitive function.
|
Day1
|
|
The global and subscores of the Mandarin version of the Mini-Mental State Examination (MMSE)
Time Frame: Day1
|
MMSE comprises six components: temporal orientation, spatial orientation, immediate memory, attention and calculation abilities, delayed memory, and language ability.
Depending on participants' accuracy in answering each test item, MMSE is scored out of 30 points.
A higher score indicates better cognitive function.
|
Day1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
better-ear PTA in the aided condition (BEPTA-A)
Time Frame: Day1
|
For the aided group, participants additionally underwent a sound field audiometry (hearing thresholds ) with their hearing aid(s) on. The stimuli were presented through two binaural speakers placed one meter from the participants at 45° azimuth via a Piano Plus diagnostic audiometer. During the test session, participants were seated in an upright position to ensure the height of the microphone(s) on their hearing aid(s) was consistent with the height of the geometric center of the speaker(s). Similarly, their better-ear PTA (BEPTA-A) in the aided condition will be collected for further analysis. |
Day1
|
|
binaural averaged PTA in the aided condition (BAPTA-A)
Time Frame: Day1
|
For the aided group, participants additionally underwent a sound field audiometry (hearing thresholds ) with their hearing aid(s) on. The stimuli were presented through two binaural speakers placed one meter from the participants at 45° azimuth via a Piano Plus diagnostic audiometer. During the test session, participants were seated in an upright position to ensure the height of the microphone(s) on their hearing aid(s) was consistent with the height of the geometric center of the speaker(s). Similarly, their binaural averaged PTA (BAPTA-A) in the aided condition will be collected for further analysis. |
Day1
|
|
better-ear SRT in the aided condition (BESRT-A)
Time Frame: Day1
|
For the aided group, participants additionally underwent a sound field audiometry (hearing thresholds ) with their hearing aid(s) on. The stimuli were presented through two binaural speakers placed one meter from the participants at 45° azimuth via a Piano Plus diagnostic audiometer. During the test session, participants were seated in an upright position to ensure the height of the microphone(s) on their hearing aid(s) was consistent with the height of the geometric center of the speaker(s). Similarly, their better-ear SRT (BESRT-A) in the aided condition will be collected for further analysis. |
Day1
|
|
binaural averaged SRT in the aided condition (BASRT-A)
Time Frame: Day1
|
For the aided group, participants additionally underwent a sound field audiometry (hearing thresholds ) with their hearing aid(s) on. The stimuli were presented through two binaural speakers placed one meter from the participants at 45° azimuth via a Piano Plus diagnostic audiometer. During the test session, participants were seated in an upright position to ensure the height of the microphone(s) on their hearing aid(s) was consistent with the height of the geometric center of the speaker(s). Similarly, their binaural averaged SRT (BASRT-A) in the aided condition will be collected for further analysis. |
Day1
|
|
the global score of Pittsburgh sleep quality index (PSQI)
Time Frame: Day1
|
PSQI scale was compiled by Buysse et al in 1989 to assess the sleep quality of individuals in the last 1 month.
The total score ranges from 0 to 21.
A higher score indicates worse sleep quality in the past month.
|
Day1
|
|
the global score of Hamilton Depression Scale -24 items (HAMD-24)
Time Frame: Day1
|
The HAMD-24 was used to assess the degree of depression and emotional state in patients with chronic subjective tinnitus.
The assessment included the emotional state and symptoms of autonomic nervous system disorders in the past week, and each question was scored according to the presence and severity of symptoms.
The total score ranges from 0 to 76.
A higher score indicates worse emotion state in the past week.
|
Day1
|
|
the global score of 15-item Geriatric Depression Scale (GDS-15)
Time Frame: Day1
|
GDS-15 is a self-rated depression questionnaire, with higher scores indicating a worse depressive state.
The total score ranges from 0 to 15.
A higher score indicates worse emotion state in the past week.
|
Day1
|
Collaborators and Investigators
Investigators
- Study Director: Haidi Yang, Prof., SunYatSunU2H
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SYSKY-2024-938-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on hearing aids
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHearing Loss, Sensorineural | Age-related Hearing LossChina
-
University Hospital, ToursCompletedHearing Loss | Alzheimer's DiseaseFrance
-
University of PretoriaChildren's Hospital Medical Center, Cincinnati; National Institute on Deafness...Recruiting
-
Sonova AGUniversity of South FloridaRecruitingHearing Loss, BilateralUnited States
-
Sonova AGCompletedSensorineural Hearing LossSwitzerland
-
Northwestern UniversityUniversity of Colorado, BoulderCompleted
-
Jong Woo ChungCompletedAuditory Processing Disorder, CentralKorea, Republic of
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHearing Loss, Sensorineural | Cognitive Function Abnormal | Age-related Hearing Loss | Hearing AidChina
-
VA Office of Research and DevelopmentCompleted
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom